drugset / Trial / NCT03035812

Alkalinization by Urologists & Nephrologists

NCT03035812

Phase 4 Completed 156 enrolled Jean-Philippe Bertocchio
NaSingle-groupOpen-labelTreatment

Summary

Metabolic acidosis recovers a wide range of diseases in which an oral alkalinization could be useful. This therapeutic intervention has been said to increase extracellular volume leading to rising blood pressure. No prospective data has been published in clinical routine. Here, investigators propose to follow patients in which an oral alkalinization is indicated: blood pressure, body weight, and a clinical evaluation of the extracellular compartment will be performed at the beginning and during the follow-up of participants. The principal criterion of evaluation will be the variation in the extracellular compartment.

Timeline

Start
2017-02-01
Primary completion
2020-02-21
Completion
2020-02-21

Drugs

EvaluationDrugModalityDoseRoute
Subject citrate Unknown Oral
Subject sodium bicarbonate Diagnostic / imaging agent Oral